Rafferty Asset Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
239,824
-33,760
-12% -$171K ﹤0.01% 734
2025
Q4
$1.17M Buy
+273,584
New +$1.04M ﹤0.01% 766
2022
Q1
Sell
-152,369
Closed -$660K 1237
2021
Q4
$660K Sell
152,369
-5,932
-4% -$34.8K ﹤0.01% 1010
2021
Q3
$806K Sell
158,301
-36,985
-19% -$198K 0.01% 922
2021
Q2
$1.24M Buy
195,286
+32,629
+20% +$254K 0.01% 811
2021
Q1
$1.26M Buy
162,657
+145,950
+874% +$1.16M 0.01% 718
2020
Q4
$109K Sell
16,707
-32,101
-66% -$229K ﹤0.01% 1002
2020
Q3
$325K Buy
48,808
+26,638
+120% +$198K ﹤0.01% 789
2020
Q2
$185K Buy
+22,170
New +$206K ﹤0.01% 932
2019
Q4
Sell
-65,510
Closed -$483K 877
2019
Q3
$483K Sell
65,510
-7,131
-10% -$70.3K 0.01% 667
2019
Q2
$815K Sell
72,641
-17,854
-20% -$187K 0.01% 600
2019
Q1
$973K Buy
+90,495
New +$1.34M 0.02% 554

Other funds holding CTMX